Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Checkpoint Immunotherapy Is Associated with Preferential Activation of Tumor-Antigen Specific CD4 + T Cells in MDS

Elizabeth A. Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, Junko Matsuzaki, Kunle Odunsi, Laura W Dillon, Devdeep Mukherjee, Christopher S. Hourigan, Jacqueline Peng, Shovik Bandyopadhyay, Kai Tan, Krista Belko, Amanda C. Przespolewski, Eunice S. Wang, Prashant Singh, Jianmin Wang, Michael J. Nemeth

Blood (2023) 142 (Supplement 1): 4602.

https://doi.org/10.1182/blood-2023-178756

Published: 2023

Journal Articles

Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents

Shipra Goel, Brahm Segal, Elizabeth A. Griffiths, Francisco Hernandez-Ilizaliturri, Pallawi Torka, Matthew J Cortese, Paola Ghione, Michael J. Nemeth, Jason Muhitch

Blood (2022) 140 (Supplement 1): 6468–6469.

https://doi.org/10.1182/blood-2022-170369

Published: 2022

Journal Articles

Impact of Therapy on the Anamnestic Response to Seasonal Influenza Vaccination in Patients with Myeloid Malignancies

Kyle R Wiatrowski, Pragya Srivastava, Alan Hutson, Hana Golding, Surender Khurana, Lisa King, Jody Manischewitz, Molly Sheehan, Pankit Vachhani, Amanda Przespolewski, James E. Thompson, Eunice S. Wang, Michael J Nemeth, Elizabeth A. Griffiths

Blood (2022) 140 (Supplement 1): 315–316.

https://doi.org/10.1182/blood-2022-162720

Published: 2022

Journal Articles

Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia

Lorenza Bellusci, Gabrielle Grubbs, Pragya Srivastava, Michael J. Nemeth, Elizabeth A. Griffiths, Hana Golding, Surender Khurana

Blood (2022) 139 (18): 2842–2846.

https://doi.org/10.1182/blood.2022016087

Published: 2022

Includes: Supplemental data

Journal Articles

Inhibition of LSD1 in Myelodysplastic Syndrome Progenitors Restores Differentiation of CD141 Hi Conventional Dendritic Cells

Pragya Srivastava, PhD, Stephanie Tzetzo, Eduardo Cortes Gomez, Kevin Eng, Prashant K Singh, PhD, Kitty De Jong, Sheila N. J. Sait, PhD, Kyle Wiatrowski, Miranda L Lynch, PhD, Jennifer Peresie, BS, Jianmin Wang, PhD, Elizabeth A. Griffiths, MD, Michael J. Nemeth, PhD

Blood (2019) 134 (Supplement_1): 1695.

https://doi.org/10.1182/blood-2019-126220

Published: 2019

Journal Articles

Quantification of Humoral Immune Response to Influenza Vaccination in MDS

Pankit Vachhani, MD, Kyle Wiatrowski, Pragya Srivastava, PhD, Lisa King, Jody Manischewitz, Hana Golding, Heather L Bashaw, BA, Ava R. Dimitroff, Amanda Przespolewski, DO, James E. Thompson, MD, Swapna Thota, MD, Eunice S. Wang, MD, Michael J. Nemeth, PhD, Elizabeth A. Griffiths, MD

Blood (2019) 134 (Supplement_1): 4756.

https://doi.org/10.1182/blood-2019-126176

Published: 2019

Journal Articles

Evidence of Targetable Immune Dysfunction in the Bone Marrow of Patients with Intermediate/High-Risk Myelodysplastic Syndrome Refractory to Hypomethylating Agents

Cherie Green, Mark Yan, Stefani Nalle, Connie Ma, Alberto Robert, Judy Zhong, Kartik Krishnan, Patrick Phuong, PharmD, John Byon, Paul Woodard, Michael J. Nemeth, PhD, Elizabeth A. Griffiths, MD, Joanne I. Adamkewicz, Jeffrey M. Venstrom, Monique Dail

Blood (2017) 130 (Supplement 1): 4241.

https://doi.org/10.1182/blood.V130.Suppl_1.4241.4241

Published: 2017

Journal Articles

Patients with MDS Demonstrate Reduced Numbers and Impaired Differentiation of CD141 Hi Conventional Dendritic Cells

Pragya Srivastava, PhD, Elizabeth A. Griffiths, MD, Prashant Singh, PhD, Eduardo Cortes Gomez, BS, Eunice S. Wang, MD, LaurieAnn Ford, BS, Jianmin Wang, PhD, Michael J. Nemeth, PhD

Blood (2017) 130 (Supplement 1): 2955.

https://doi.org/10.1182/blood.V130.Suppl_1.2955.2955

Published: 2017

Journal Articles

Vaccination with NY-ESO-1 in Combination with Decitabine for Patients with MDS

Pragya Srivastava, PhD, Junko Matsuzaki, Benjamin E. Paluch, Stephanie Kaufman, Adam R. Karpf, PhD, Kunle Odunsi, MD PhD, Austin Miller, PhD, Justin Kocent, Eunice S. Wang, MD, Michael J. Nemeth, PhD, Elizabeth A. Griffiths, MD

Blood (2016) 128 (22): 4326.

https://doi.org/10.1182/blood.V128.22.4326.4326

Published: 2016

Journal Articles

Induction of Cancer Testis Antigen Expression in Circulating Acute Myeloid Leukemia Blasts Following Hypomethylating Agent Monotherapy

Pragya Srivastava, PhD, Benjamin E. Paluch, Junko Matsuzaki, PhD, Smitha R. James, Golda Collmat-Lai, Nadja Blagitko-Dorfs, Laurie Ann Ford, Rafeh Naqash, MD, Michael Luebbert, MD, Adam R. Karpf, PhD, Michael J. Nemeth, PhD, Elizabeth A. Griffiths, MD

Blood (2015) 126 (23): 2537.

https://doi.org/10.1182/blood.V126.23.2537.2537

Published: 2015

Journal Articles

NY-ESO-1 Vaccination in Combination with Decitabine for Patients with MDS Induces CD4+ and CD8+ T-Cell Responses

Pragya Srivastava, PhD, Junko Matsuzaki, PhD, Benjamin E. Paluch, Zachary Brumberger, Stephanie Kaufman, Adam R. Karpf, PhD, Kunle Odunsi, MDPhD, Austin Miller, PhD, Justin Kocent, Eunice S. Wang, MD, Michael J. Nemeth, PhD, Elizabeth A. Griffiths, MD

Blood (2015) 126 (23): 2873.

https://doi.org/10.1182/blood.V126.23.2873.2873

Published: 2015

Journal Articles

SGI-110, a Novel Hypomethylating Agent, Induces the WNT Inhibitor Secreted Frizzled Related Protein-2 ( SFRP2 ), and Down Regulates β-Catenin in Acute Myeloid Leukemia (AML) Cells

Michelle Golding, Pragya Srivastava, PhD, Golda Collamat, MS, Smitha R James, MS, Adam R. Karpf, PhD, Michael J. Nemeth, PhD, Elizabeth A Griffiths, MD

Blood (2012) 120 (21): 1290.

https://doi.org/10.1182/blood.V120.21.1290.1290

Published: 2012

Journal Articles

Non-Canonical Wnt Signaling Regulates Hematopooetic Repopulation Through the Ryk Receptor

Benjamin Povinelli, Michael J. Nemeth, PhD

Blood (2012) 120 (21): 852.

https://doi.org/10.1182/blood.V120.21.852.852

Published: 2012

Journal Articles

Elevating body temperature enhances hematopoiesis and neutrophil recovery after total body irradiation in an IL-1–, IL-17–, and G-CSF–dependent manner

Maegan L. Capitano, Michael J. Nemeth, Thomas A. Mace, Christi Salisbury-Ruf, Brahm H. Segal, Philip L. McCarthy, Elizabeth A. Repasky

Blood (2012) 120 (13): 2600–2609.

https://doi.org/10.1182/blood-2012-02-409805

Published: 2012

Includes: Supplemental data

Journal Articles

Hmgb3 deficiency deregulates proliferation and differentiation of common lymphoid and myeloid progenitors

Michael J. Nemeth, Amanda P. Cline, Stacie M. Anderson, Lisa J. Garrett-Beal, David M. Bodine

Blood (2005) 105 (2): 627–634.

https://doi.org/10.1182/blood-2004-07-2551

Published: 2005

Journal Articles

Hmgb3 Deficiency Inhibits Down-Regulation of c-kit in Hematopoietic Stem Cells.

Michael J. Nemeth, Stacie M. Anderson, Lisa J. Garrett-Beal, David M. Bodine

Blood (2004) 104 (11): 372.

https://doi.org/10.1182/blood.V104.11.372.372

Published: 2004

Journal Articles

Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation

Michael J. Nemeth, David J. Curtis, Martha R. Kirby, Lisa J. Garrett-Beal, Nancy E. Seidel, Amanda P. Cline, David M. Bodine

Blood (2003) 102 (4): 1298–1306.

https://doi.org/10.1182/blood-2002-11-3541

Published: 2003

NARROW

Checkpoint Immunotherapy Is Associated with Preferential Activation of Tumor-Antigen Specific CD4 + T Cells in MDS

Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents

Impact of Therapy on the Anamnestic Response to Seasonal Influenza Vaccination in Patients with Myeloid Malignancies

Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia

Inhibition of LSD1 in Myelodysplastic Syndrome Progenitors Restores Differentiation of CD141 Hi Conventional Dendritic Cells

Quantification of Humoral Immune Response to Influenza Vaccination in MDS

Evidence of Targetable Immune Dysfunction in the Bone Marrow of Patients with Intermediate/High-Risk Myelodysplastic Syndrome Refractory to Hypomethylating Agents

Patients with MDS Demonstrate Reduced Numbers and Impaired Differentiation of CD141 Hi Conventional Dendritic Cells

Vaccination with NY-ESO-1 in Combination with Decitabine for Patients with MDS

Induction of Cancer Testis Antigen Expression in Circulating Acute Myeloid Leukemia Blasts Following Hypomethylating Agent Monotherapy

NY-ESO-1 Vaccination in Combination with Decitabine for Patients with MDS Induces CD4+ and CD8+ T-Cell Responses

SGI-110, a Novel Hypomethylating Agent, Induces the WNT Inhibitor Secreted Frizzled Related Protein-2 ( SFRP2 ), and Down Regulates β-Catenin in Acute Myeloid Leukemia (AML) Cells

Non-Canonical Wnt Signaling Regulates Hematopooetic Repopulation Through the Ryk Receptor

Elevating body temperature enhances hematopoiesis and neutrophil recovery after total body irradiation in an IL-1–, IL-17–, and G-CSF–dependent manner

Hmgb3 deficiency deregulates proliferation and differentiation of common lymphoid and myeloid progenitors

Hmgb3 Deficiency Inhibits Down-Regulation of c-kit in Hematopoietic Stem Cells.

Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only